Trade SKYE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Skye Bioscience, Inc. (SKYE) is trading at US$1.67, up 2.90% today as of Oct 7, 13:29 EDT. The company has a market capitalisation of US$1.24M. Over the past 52 weeks, SKYE has traded between US$1.50 and US$14.51. On Syfe you can trade SKYE with $0 commission and add it to your watchlist.
| Previous close | US$1.62 |
|---|---|
| Market cap | US$1.24M |
| 52-week range | US$1.50 – US$14.51 |
| Volume | 30.8K |
| Exchange | US |
Skye Bioscience, Inc.
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the business of research and development activities related to developing medicine for obesity and metabolic diseases. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Year: 2014
Skye Bioscience, Inc. (SKYE) stock is trading at US$1.67, +2.90% from the previous close of US$1.62.
The market cap for Skye Bioscience, Inc. (SKYE) stock is approximately US$1.24M.
The 52-week high for Skye Bioscience, Inc. (SKYE) stock is US$14.51.
The 52-week low for Skye Bioscience, Inc. (SKYE) stock is US$1.50.
Skye Bioscience, Inc. (SKYE) does not currently pay a dividend.
Stay on top of SKYE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
